A Phase I/II Study of the Safety and Immunogenicity of a Recombinant Human Parvovirus B-19 Vaccine
Phase of Trial: Phase I/II
Latest Information Update: 12 Aug 2011
At a glance
- Drugs MF 59; Parvovirus vaccine
- Indications Parvovirus infections
- Focus Adverse reactions; Pharmacodynamics
- 12 May 2009 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 12 Feb 2009 Status changed from suspended to completed, according to ClinicalTrials.gov.
- 17 Apr 2008 The expected completion date for this trial is now 1 Sep 2009.